课题基金 / 基金详情

A microfluidic blood-brain barrier model with on-chip cell barrier biosensing**

A microfluidic blood-brain barrier model with on-chip cell barrier biosensing**
具有片上细胞屏障生物传感的微流体血脑屏障模型**
批准号:
531083-2018
负责人:
Simmons, Craig
金额:
$6.78万
依托单位:
依托单位国家:
加拿大
项目类别:
Collaborative Research and Development Grants
财政年份:
2018
资助国家:
加拿大
项目状态:
已结题
起止时间:
2018-01-01 至 2019-12-31

项目摘要

项目成果

Simmons, Craig的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We are developing a high throughput, easy-to-use microfluidic system, used to model the interface between blood vessels and tissues for drug screening, transport studies and basic research, with a first application in blood brain barrier (BBB) modelling. Transport of drugs across the BBB is of prime interest to the pharmaceutical and biotechnology industries because the BBB is impermeable to many drugs, making neurological diseases difficult to treat. Development of neurological drugs is hampered by poor model systems, as animal models often fail to replicate human biology and current laboratory models of the BBB inadequately replicate the environment in the body, leading to poor predictive power.** We have developed a microfluidic cell culture system that addresses the unmet need for advanced cell culture systems that better replicate human biology for drug development. The focus of this proposal is to improve the functionality of our system by integrating electrical sensors to monitor the quality of the BBB model directly on the platform. This is an essential feature of BBB models, but is not incorporated into any commercially-available organ-on-a-chip platform.** In partnership with CellScale Biomaterials, an Ontario-based biotechnology manufacturing company, we will optimize the design of the electrodes and sensing system, integrate it into our microfluidic platform, validate its application for BBB modeling, and develop scalable manufacturing processes for commercial translation.** CellScale is strongly supporting this project through both cash and in-kind contributions. They are uniquely positioned in Canada to leverage the research outputs of this project to develop products that will be market-ready within two years, contribute to the development of highly qualified personnel, generate new jobs, and contribute to economic growth in Canada as a new R&D and manufacturing centre for advanced cell culture biotechnologies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Integrated biosensors for organ-on-a-chip and physiological monitoring platforms
  • 批准号:
    RGPIN-2022-04375
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $4.66万
  • 财政年份:
    2022
  • 负责人:
    Simmons, Craig
  • 依托单位:
Melt electrowrite system for biofabrication of complex engineered tissues
  • 批准号:
    RTI-2023-00475
  • 项目类别:
    Research Tools and Instruments
  • 资助金额:
    $10.93万
  • 财政年份:
    2022
  • 负责人:
    Simmons, Craig
  • 依托单位:
Biosensing for organ-on-a-chip platforms
  • 批准号:
    RGPIN-2016-06026
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $3.86万
  • 财政年份:
    2021
  • 负责人:
    Simmons, Craig
  • 依托单位:
Biosensing for organ-on-a-chip platforms
  • 批准号:
    RGPIN-2016-06026
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $3.86万
  • 财政年份:
    2020
  • 负责人:
    Simmons, Craig
  • 依托单位:
国内基金
海外基金
基于MFSD2A调控血迷路屏障跨细胞囊泡转运机制的噪声性听力损失防治研究
  • 批准号:
    82371144
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    汪雪玲
  • 依托单位:
内源性蛋白酶抑制剂SerpinA3N对缺血性脑卒中后血脑屏障的保护作用及其表达调控机制
  • 批准号:
    82371317
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    万杰清
  • 依托单位:
KLK10调控胶质—血管耦合与对话促缺血性卒中后血脑屏障修复的机制
  • 批准号:
    82371465
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    李龙宣
  • 依托单位:
骨骼肌中胰高血糖素受体的表达及其调控血糖稳态的作用与机制研究
  • 批准号:
    82370820
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    王天歌
  • 依托单位: